Check out our most popular compounded medications! Get Started
Dexmedetomidine Hydrochloride is a highly selective alpha-2 adrenergic agonist used primarily for its sedative and analgesic properties.
Dexmedetomidine Hydrochloride is a highly selective alpha-2 adrenergic agonist, primarily used for its sedative and analgesic properties. It is commonly utilized in various medical settings, including intensive care units and surgical procedures, due to its ability to provide sedation without causing significant respiratory depression.
This API is particularly valued for its role in facilitating patient comfort and cooperation during procedures that require minimal to moderate sedation. Dexmedetomidine Hydrochloride's unique pharmacological profile allows for a more predictable sedation experience, making it a preferred choice for healthcare providers.
In addition to its sedative effects, Dexmedetomidine Hydrochloride exhibits anxiolytic and analgesic properties, which can be beneficial in managing pain and anxiety in patients. Its use can lead to a reduction in the need for additional analgesics and anxiolytics, thereby minimizing potential side effects associated with polypharmacy.
Dexmedetomidine Hydrochloride is metabolized primarily in the liver, and its clearance can be affected by factors such as hepatic impairment. Therefore, careful consideration and dosage adjustments may be necessary for patients with liver dysfunction to ensure safe and effective use.
Overall, Dexmedetomidine Hydrochloride is a versatile API that offers significant benefits in sedation management, with a safety profile that supports its use in a variety of clinical scenarios. Its incorporation into compounded formulations allows for tailored dosing and administration, enhancing its applicability in personalized patient care.
Each of these is compounded to order at our Warwick, Rhode Island pharmacy and requires a prescription.
A sample of preparations from our formulary. Strengths and dose forms are customised to the prescription.
No. Its use in palliative care is emerging and investigational. Reports in the literature describe subcutaneous and intravenous infusion for refractory agitation and as an opioid-sparing adjunct, but the evidence base is limited and it is not an established standard of care.
Bradycardia and hypotension are the dose-limiting effects reported. Bayview compounds it on a patient-specific prescription; whether it is appropriate for a given patient is the prescriber's judgment.
Other salt forms of this molecule, and ingredients commonly compounded alongside it.
This page describes an active pharmaceutical ingredient, not a finished drug product. Bayview Pharmacy compounds preparations containing it only on a prescriber's order for an individual patient.
Compounded preparations are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or manufacturing quality. Nothing on this page is a claim that any preparation is effective for any condition.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Our pharmacists work with prescribers to build preparations around a patient's dose, form and tolerances. Ask us what is possible with this ingredient.
